M
Mohammad Taghi Kardi
Researcher at University of Isfahan
Publications - 15
Citations - 253
Mohammad Taghi Kardi is an academic researcher from University of Isfahan. The author has contributed to research in topics: Multiple sclerosis & Genotype. The author has an hindex of 7, co-authored 15 publications receiving 217 citations.
Papers
More filters
Journal ArticleDOI
Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study
Sayyed Hamid Zarkesh-Esfahani,Sayyed Hamid Zarkesh-Esfahani,Mohammad Taghi Kardi,Masoud Edalati +3 more
TL;DR: Genotype 3a is the most frequent followed by the genotypes 1a, genotype 1b and genotype 2 in Isfahan province, Iran, which provides important information which can be used to determine the type and duration of therapy and to predict the outcome of the disease.
Journal ArticleDOI
Anticancer effects of silver nanoparticles encapsulated by Taxus baccata extracts
Abolghasem Abbasi Kajani,Sayyed Hamid Zarkesh-Esfahani,Abdol-Khalegh Bordbar,Ahmad Reza Khosropour,Amir Razmjou,Mohammad Taghi Kardi +5 more
TL;DR: It can be concluded that the preparation method and stabilizing agents may have major effects on the biological activity of nanoparticles as well as their physicochemical properties.
Journal Article
Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis.
Nima Sanadgol,Nourollah Ramroodi,Ghasem Ali Ahmadi,Majid Komijani,Ali Moghtaderi,Majid Bouzari,Marzieh Rezaei,Mohammad Taghi Kardi,Soroush Dabiri,Malek Moradi,Ehsan Sanadgol +10 more
TL;DR: The hypothesis that CMV may contribute to MS thought to establish systemic infection process and induce immune response is supported.
Journal ArticleDOI
Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism in Iranian Women With Idiopathic Recurrent Pregnancy Losses
TL;DR: Investigation of the distributions of various genotypes of MTHFR C677T and A1298C did not indicate a significant difference between patients with RPL and healthy control subjects, suggesting that MTH FR mutations might not be associated with R PL in the examined population.
Journal ArticleDOI
Promising effect of rapamycin on multiple sclerosis
Bahram Bagherpour,Mansoor Salehi,Rasool Jafari,Akram Bagheri,Abbas Kiani-Esfahani,Masoud Edalati,Mohammad Taghi Kardi,Vahid Shaygannejad +7 more
TL;DR: A promising response to rapamycin is found among the authors' cases with minor side effects and it may be considered as a therapeutic option of this disease.